Loading clinical trials...
Loading clinical trials...
The purpose of the study is to investigate the routes of elimination and overall mass balance of 100 mg quemliclustat containing 75 μCi \[14C\] following a single IV infusion of \[14C\]-quemliclustat ...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Arcus Biosciences, Inc.
NCT07554365 · Healthy Volunteer, Healthy Participants Study
NCT07401472 · Healthy Participants Study
NCT07310901 · Obese But Otherwise Healthy Participants
NCT06342713 · Healthy Participants, Healthy Subjects, and more
NCT07471204 · Osteoarthritis of Knee, Healthy Participants
Celerion
Lincoln, Nebraska
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions